Changlong Song
Research Subjects
Research Interests
Changlong Song has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Dayi Zhou
Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
1 shared publication Keyi Wu
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, China
1 shared publicationLiang Sun
Department of Breast Surgery, China-Japan Union Hospital of Jilin University
1 shared publicationLijuan Bao
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, China
1 shared publicationQiujie Chen
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, China
1 shared publicationRuping Shan
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, China
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (9) , e0285924
Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway
Mastitis, one of the most prevalent diseases in humans and animals, is commonly caused by local infection of the mammary gland. Puerarin inhibits mitochondrial oxidative stress and acute liver injury in mice. However, the therapeutic effect of puerarin on Staphylococcus aureus -induced mastitis is still not well understood. This study was designed to investigate the therapeutic role and mechanism of puerarin on S. aureus -induced mastitis. S. aureus was injected through the mammary gland to induce mouse mastitis. Puerarin was administered to mastitis mice via intraperitoneal injection. The iron concentration was measured using an iron assay. TNF-α and IL-1β levels in the mammary gland tissues were assessed using the ELISA kits. The signaling pathways were detected by western blot analysis. Hematoxylin and eosin staining revealed that puerarin reversed pathological injury to mammary gland tissue induced by S. aureus . Puerarin also inhibited TNF-α and IL-1β production induced by S. aureus . The significant increases in iron concentration, myeloperoxidase activity, and the malondialdehyde (MDA) level in the mammary gland tissue were attenuated by puerarin. Moreover, puerarin treatment significantly reversed the decreases in the relative glutathione (GSH) and GPX4 expression. In addition, puerarin increased the expression of SIRT1 and solute carrier family 7 member 11 (SLC7A11) and decreased p53 expression. In vitro , the inhibitory effects of puerarin on S. aureus -induced inflammation and ferroptosis were prevented by the SIRT1 inhibitor EX-527. In conclusion, the therapeutic mechanism of puerarin involves the activation of the SIRT1/p53/SLC7A11 pathway to inhibit ferroptosis and the inflammatory response. IMPORTANCE: Antibiotics are the main drugs used to treat mastitis, but they can easily cause bacterial resistance and food safety issues. Therefore, finding safe and effective drugs is crucial to prevent and treat mastitis. Puerarin is the main isoflavonoid active ingredient in Pueraria lobata and has a wide range of pharmacological effects. We found that it could attenuate mastitis induced by Staphylococcus aureus .
- 2 September 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (9) , e0285924
Open AccessPuerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway
Mastitis, one of the most prevalent diseases in humans and animals, is commonly caused by local infection of the mammary gland. Puerarin inhibits mitochondrial oxidative stress and acute liver injury in mice. However, the therapeutic effect of puerarin on Staphylococcus aureus -induced mastitis is still not well understood. This study was designed to investigate the therapeutic role and mechanism of puerarin on S. aureus -induced mastitis. S. aureus was injected through the mammary gland to induce mouse mastitis. Puerarin was administered to mastitis mice via intraperitoneal injection. The iron concentration was measured using an iron assay. TNF-α and IL-1β levels in the mammary gland tissues were assessed using the ELISA kits. The signaling pathways were detected by western blot analysis. Hematoxylin and eosin staining revealed that puerarin reversed pathological injury to mammary gland tissue induced by S. aureus . Puerarin also inhibited TNF-α and IL-1β production induced by S. aureus . The significant increases in iron concentration, myeloperoxidase activity, and the malondialdehyde (MDA) level in the mammary gland tissue were attenuated by puerarin. Moreover, puerarin treatment significantly reversed the decreases in the relative glutathione (GSH) and GPX4 expression. In addition, puerarin increased the expression of SIRT1 and solute carrier family 7 member 11 (SLC7A11) and decreased p53 expression. In vitro , the inhibitory effects of puerarin on S. aureus -induced inflammation and ferroptosis were prevented by the SIRT1 inhibitor EX-527. In conclusion, the therapeutic mechanism of puerarin involves the activation of the SIRT1/p53/SLC7A11 pathway to inhibit ferroptosis and the inflammatory response. IMPORTANCE: Antibiotics are the main drugs used to treat mastitis, but they can easily cause bacterial resistance and food safety issues. Therefore, finding safe and effective drugs is crucial to prevent and treat mastitis. Puerarin is the main isoflavonoid active ingredient in Pueraria lobata and has a wide range of pharmacological effects. We found that it could attenuate mastitis induced by Staphylococcus aureus .
- 29 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 140, 112818
Ferroptosis is involved in Staphylococcus aureus-induced mastitis through autophagy activation by endoplasmic reticulum stress
- 29 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 140, 112818
Ferroptosis is involved in Staphylococcus aureus-induced mastitis through autophagy activation by endoplasmic reticulum stress